Subscribe to Newsletter
Business & Profession Other

The (Dark) Art of Public Relations!

For over a decade, I have spent the third Monday evening of each month in a local pub, where I run a SciBar. What is a SciBar? It gives local researchers the chance to present their work to the public; the scientists improve their communication skills, and the public gains a greater understanding of science. It’s great fun.

At the last SciBar, four PhD students presented: How Much Do You Trust a Science Headline? The highlight was the paper in Nature Communications: Fenamate NSAIDs inhibit the NLRP inflammasome and protect against Alzheimer’s disease in rodent models (1), which turned into the headline: “Only 3p – the cost of the pill that could beat Alzheimer’s” in the Daily Mail. The research group was inundated by calls from the press asking for interviews and, more sadly, from patients and their families in search of what the press was implying was a cure. Then the conversation turned to science communication in general: how do you get people to understand your work – especially when it’s medical research – when the filter through the popular press distorts the message? I thought I’d share our ideas in the hope that some of you might find it useful.

Maximum result for minimum effort. Whether it’s explaining the inflammasome or promoting your premium IOL practice, focus your efforts on what will give you the maximum exposure to your target audience. And today, that still means the mainstream media (MSM).

When you’re dealing with the MSM, there are three key ways to get your message across. First, you should write the article yourself; find the best possible angle, pitch it at the level of the intended audience, and send it as a press release to every journalist and TV news producer you can find. Journalists often have to write at least 10 articles a day – make it easy for them by doing it for them. Second, a picture paints a thousand words. If you have a print-quality, simple and clear graphic that illustrates your work, use it. If you don’t, make one. Place it on your website, and get it out with the press release. Third, take a leaf from the PR and communications agencies by writing what’s known as an ‘objection handler’ – essentially a well-thought FAQ page. Try to guess all of the questions that might be asked, list them, and provide the answers. These will all help reduce the chance of your work being misinterpreted and misreported – and increase the chance of your work (or what your practice can do) being reported as widely as possible.

So, hijack the dark arts of PR, and use the inner workings of the MSM to educate to your advantage!

Mark Hillen
Editor

Receive content, products, events as well as relevant industry updates from The Ophthalmologist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

  1. MJ Daniels et al, “Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer’s disease in rodent models ”, Nat Commun, 7, 12504 (2016). PMID: 27509875.
About the Author
Mark Hillen

I spent seven years as a medical writer, writing primary and review manuscripts, congress presentations and marketing materials for numerous – and mostly German – pharmaceutical companies. Prior to my adventures in medical communications, I was a Wellcome Trust PhD student at the University of Edinburgh.

Product Profiles

Access our product directory to see the latest products and services from our industry partners

Here
Most Popular
Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: